A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2005

Conditions
HIV InfectionsHepatitis B
Interventions
DRUG

Adefovir dipivoxil

DRUG

Tenofovir disoproxil fumarate

Trial Locations (15)

10003

Beth Israel Med. Ctr., ACTU, New York

10016

NY Univ. HIV/AIDS CRS, New York

10021

Cornell CRS, New York

21287

Johns Hopkins Adult AIDS CRS, Baltimore

37203

Vanderbilt Therapeutics CRS, Nashville

60611

Northwestern University CRS, Chicago

60612

Cook County Hosp. CORE Ctr., Chicago

80262

University of Colorado Hospital CRS, Aurora

94110

Ucsf Aids Crs, San Francisco

95814

UC Davis Medical Center, Sacramento

98104

University of Washington AIDS CRS, Seattle

441091998

MetroHealth CRS, Cleveland

452670405

Univ. of Cincinnati CRS, Cincinnati

Unknown

Univ. of California Davis Med. Ctr., ACTU, Sacramento

Weill Med. College of Cornell Univ., The Cornell CTU, New York

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH